Start with named responsibilities, then decide whether each requires a full-time hire. The following is a proposed operating design for this desk’s target buyer—not an observed industry staffing ratio.
| Capability | Suggested accountable owner | First deliverable | Trigger for considering dedicated capacity |
|---|---|---|---|
| Pharmacy-partner selection and commercial management | COO or pharmacy-partnerships lead | Product-and-state partner matrix; comparable quotations; decision log | Renewals, multiple partners or expansion repeatedly exceed existing management capacity |
| Patient-access workflow management | Access or clinical-operations manager | Queue definitions, escalation rules and patient-status reporting | Recurring unresolved cases, inconsistent handoffs or persistent backlog |
| Routine coordination | Appropriately qualified access staff | Complete case records and documented next actions | Measured handling workload exceeds available productive hours |
| Clinical oversight | Medical director or delegated clinical leader | Clinical escalation and prescribing-governance procedures | Clinical complexity or supervision requirements exceed existing capacity |
| Compliance and legal review | Compliance owner with qualified counsel | Dated supplier-evidence register and approval questions | New routes, products, states or contractual structures |
| Cost and performance analysis | Finance or operations analyst | Cost-per-fulfilled-patient-month model and partner scorecard | No reliable view of avoidable handling cost, service failures or commitments |
For a smaller regional group, one operations lead may coordinate several administrative capabilities. For an acquired or multi-site platform, a central analyst and contract owner may be more useful than immediately appointing a senior procurement executive. These are organisational options to test against workload and decision complexity, not prescriptions based on prescriber count.
What should a pharmacy-partnerships job specification include?
A useful clinic-side specification should make the employee responsible for producing:
- A verified register of counterparties and facilities, with unresolved evidence clearly marked.
- A product-and-destination-state coverage matrix.
- Comparable commercial schedules showing who pays each charge.
- Service-level reporting with an agreed start and stop point for each measure.
- An exception and escalation process shared with clinical operations.
- A transition plan covering outstanding prescriptions, patient communications and responsibilities.
- A decision record separating commercial recommendation from clinical and legal approval.
Assess candidates with a redacted work sample: two non-comparable pharmacy proposals, a fictional state-expansion plan and an exception log. Ask them to identify missing evidence and propose a decision process—not to pronounce a compounded product lawful.
Explore the table row by row
A working view of the research
Pharmacy-partner selection and commercial management
- Suggested accountable owner
- COO or pharmacy-partnerships lead
- First deliverable
- Product-and-state partner matrix; comparable quotations; decision log
- Trigger for considering dedicated capacity
- Renewals, multiple partners or expansion repeatedly exceed existing management capacity
Sources cited on this page
See the section’s source register for the research context.
Section sources →